| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.00092 | 1 |